FATE – Fate Therapeutics, Inc.
Fate Therapeutics, Inc.FATE
$1.11Name : Fate Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $127,202,672.00
EPSttm : -1.64
Fate Therapeutics, Inc.
$1.11
5.71%$0.06Float Short %
15.82
Margin Of Safety %
Put/Call OI Ratio
0.15
EPS Next Q Diff
-0.07
EPS Last/This Y
0.18
EPS This/Next Y
0.21
Price
1.11
Target Price
6.72
Analyst Recom
2.42
Performance Q
-11.2
Relative Volume
0.76
Beta
2.15
Ticker: FATE
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-20 | FATE | 0.9438 | 0.14 | 0.00 | 4816 |
| 2025-03-21 | FATE | 0.9166 | 0.13 | 0.05 | 5019 |
| 2025-03-24 | FATE | 0.9468 | 0.04 | 0.00 | 4358 |
| 2025-03-25 | FATE | 0.9093 | 0.04 | 0.03 | 4391 |
| 2025-03-26 | FATE | 0.8435 | 0.04 | 0.00 | 4416 |
| 2025-03-27 | FATE | 0.87 | 0.03 | 0.00 | 4919 |
| 2025-03-28 | FATE | 0.8415 | 0.03 | 0.00 | 4931 |
| 2025-03-31 | FATE | 0.7927 | 0.03 | 0.00 | 4931 |
| 2025-04-01 | FATE | 0.7964 | 0.03 | 0.00 | 5455 |
| 2025-04-02 | FATE | 0.77 | 0.03 | 0.00 | 5455 |
| 2025-04-03 | FATE | 0.6901 | 0.03 | 0.00 | 5455 |
| 2025-04-04 | FATE | 0.7623 | 0.02 | 31.00 | 5581 |
| 2025-04-07 | FATE | 0.9385 | 0.04 | 4.68 | 5703 |
| 2025-04-08 | FATE | 0.9269 | 0.08 | 0.00 | 5917 |
| 2025-04-09 | FATE | 0.9287 | 0.08 | 0.04 | 5898 |
| 2025-04-10 | FATE | 0.9401 | 0.08 | 0.00 | 6144 |
| 2025-04-11 | FATE | 1.06 | 0.08 | 1.33 | 6142 |
| 2025-04-14 | FATE | 0.9152 | 0.08 | 0.54 | 6175 |
| 2025-04-15 | FATE | 1.12 | 0.09 | 0.11 | 6458 |
| 2025-04-16 | FATE | 1.05 | 0.10 | 58.80 | 6379 |
| 2025-04-17 | FATE | 1.12 | 0.15 | 0.00 | 6667 |
| 2025-04-18 | FATE | 1.11 | 0.15 | 0.00 | 6667 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-20 | FATE | 0.94 | 17.1 | - | -1.55 |
| 2025-03-21 | FATE | 0.91 | 17.1 | - | -1.52 |
| 2025-03-24 | FATE | 0.94 | 17.1 | - | -1.52 |
| 2025-03-25 | FATE | 0.90 | 17.1 | - | -1.52 |
| 2025-03-26 | FATE | 0.85 | 17.1 | - | -1.52 |
| 2025-03-27 | FATE | 0.88 | 17.1 | - | -1.52 |
| 2025-03-28 | FATE | 0.85 | 17.1 | - | -1.52 |
| 2025-03-31 | FATE | 0.79 | 17.1 | - | -1.52 |
| 2025-04-01 | FATE | 0.76 | 17.1 | - | -1.52 |
| 2025-04-02 | FATE | 0.77 | 17.1 | - | -1.52 |
| 2025-04-03 | FATE | 0.69 | 17.1 | - | -1.52 |
| 2025-04-04 | FATE | 0.76 | 17.9 | - | -1.49 |
| 2025-04-07 | FATE | 0.94 | 17.9 | - | -1.49 |
| 2025-04-08 | FATE | 0.91 | 17.9 | - | -1.49 |
| 2025-04-09 | FATE | 0.92 | 17.9 | - | -1.49 |
| 2025-04-10 | FATE | 0.95 | 17.9 | - | -1.49 |
| 2025-04-11 | FATE | 1.06 | 17.9 | - | -1.46 |
| 2025-04-14 | FATE | 0.92 | 19.3 | - | -1.46 |
| 2025-04-15 | FATE | 1.12 | 19.3 | - | -1.46 |
| 2025-04-16 | FATE | 1.05 | 19.3 | - | -1.46 |
| 2025-04-17 | FATE | 1.11 | 19.3 | - | -1.46 |
| 2025-04-18 | FATE | 1.11 | 19.3 | - | -1.46 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-20 | FATE | 0.22 | -13.01 | 13.53 |
| 2025-03-21 | FATE | 0.22 | -13.01 | 13.53 |
| 2025-03-24 | FATE | 0.22 | -13.01 | 12.88 |
| 2025-03-25 | FATE | 0.32 | -13.01 | 12.88 |
| 2025-03-26 | FATE | 0.32 | -13.01 | 14.08 |
| 2025-03-27 | FATE | 0.32 | -13.01 | 14.08 |
| 2025-03-28 | FATE | 0.32 | -13.01 | 14.08 |
| 2025-03-31 | FATE | 0.32 | -13.05 | 14.08 |
| 2025-04-01 | FATE | 0.32 | -13.05 | 14.08 |
| 2025-04-02 | FATE | 0.32 | -13.05 | 14.08 |
| 2025-04-03 | FATE | 0.32 | -13.05 | 14.08 |
| 2025-04-04 | FATE | 0.32 | -13.05 | 14.08 |
| 2025-04-07 | FATE | 0.32 | -12.74 | 14.08 |
| 2025-04-08 | FATE | 0.32 | -12.74 | 14.08 |
| 2025-04-09 | FATE | 0.32 | -12.74 | 14.08 |
| 2025-04-10 | FATE | 0.32 | -12.74 | 15.82 |
| 2025-04-11 | FATE | 0.32 | -12.74 | 15.82 |
| 2025-04-14 | FATE | 0.32 | -12.74 | 15.82 |
| 2025-04-15 | FATE | 0.32 | -12.74 | 15.82 |
| 2025-04-16 | FATE | 0.32 | -12.74 | 15.82 |
| 2025-04-17 | FATE | 0.32 | -12.74 | 15.82 |
| 2025-04-18 | FATE | 0.32 | -12.74 | 15.82 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.31
Avg. EPS Est. Current Quarter
-0.39
Avg. EPS Est. Next Quarter
-0.38
Insider Transactions
0.32
Institutional Transactions
-12.74
Beta
2.15
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
17
Growth Score
35
Sentiment Score
42
Actual DrawDown %
99.1
Max Drawdown 5-Year %
-99.4
Target Price
6.72
P/E
Forward P/E
PEG
P/S
9.33
P/B
0.4
P/Free Cash Flow
EPS
-1.65
Average EPS Est. Cur. Y
-1.46
EPS Next Y. (Est.)
-1.25
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1366.46
Relative Volume
0.76
Return on Equity vs Sector %
-78.4
Return on Equity vs Industry %
-65
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.19
EBIT Estimation
Fate Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 181
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
stock quote shares FATE – Fate Therapeutics, Inc. Stock Price stock today
news today FATE – Fate Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch FATE – Fate Therapeutics, Inc. yahoo finance google finance
stock history FATE – Fate Therapeutics, Inc. invest stock market
stock prices FATE premarket after hours
ticker FATE fair value insiders trading